Skip to content

Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners

Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07372859
Acronym
COEUR
Enrollment
120
Registered
2026-01-28
Start date
2026-03-22
Completion date
2026-09-30
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer

Keywords

ultra endurance

Brief summary

The goal of this clinical trial is to describe the cardiac and systemic inflammatory adaptations specific to women practicing ultra-endurance sports. The objectives are to: * Improve the understanding of cardiac and systemic inflammatory adaptations specific to women participating in ultra-endurance sports. * Assess the relationship between observed cardiac and systemic inflammatory alterations and the relative levels of estrogen, testosterone, and progesterone. * Describe the vascular adaptations specific to women participating in ultra-endurance sports. * Examine the influence of defense mechanisms on the emotional dynamics observed during and after an ultra-endurance race.

Detailed description

This is a French national non-comparative descriptive study. The study is conducted on healthy volunteers. 80 to 100 patients will be included, half of the inclusions on the "Ecotrail de Paris Ile France©"( = a trail running race in the Paris region. It is not possible to translate; it is a registered trademark) the second half of the inclusions on the "6000D©" in Savoie.

Interventions

PROCEDUREEchocardiography

6 transthoracic echocardiography will be performed: 1 before the race, 3 during the race (refreshment station), 1 at the end of the race, 1 at the follow up visit 9 days after the race. It is not possible to specify the intervention time, as this depends on the participants' running pace.

PROCEDUREArterial ultrasound

6 ultrasound of the carotid and femoral arteries will be performed: 1 before the race, 3 during the race (refreshment station), 1 at the end of the race, 1 at the follow up visit 9 days after the race. It is not possible to specify the intervention time, as this depends on the participants' running pace.

BIOLOGICALBlood sampling

6 blood sampling (2 milliliters) will be performed: 1 before the race, 3 during the race (refreshment station), 1 at the end of the race, 1 at the follow up visit 9 days after the race. It is not possible to specify the intervention time, as this depends on the participants' running pace.

BEHAVIORALScales and questionnaire

Before the race, during the race (refreshment station), and at the end of the race participant will be asked to complete the study questionnaire and scales. It is not possible to specify the intervention time, as this depends on the participants' running pace.

PROCEDUREVital signs

6 measurements of blood pressure, heart rate, respiratory rate, pulse oxygen saturation, and muscle oxygen saturation will then be taken: 1 before the race, 3 during the race (refreshment station), 1 at the end of the race, 1 at the follow up visit 9 days after the race. It is not possible to specify the intervention time, as this depends on the participants' running pace.

BIOLOGICALUrinary test

Pregnancy test will be performed before the race.

Sponsors

French Cardiology Society
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Must have a Global Positioning System watch during the race; * Must participate in one of the following races: * "Ecotrail de Paris Ile France©" (=a trail running race in the Paris region, it is not possible to translate; it is a registered trademark) 80 kilometers; * Or "la 6000D©" 69 kilometers; * Must comply with the race regulations: * Medical certificate stating no contraindications to competitive running, dated less than 12 months prior to the race; * Or a valid sports license on the day of the race. * Must agree to participate in the study, sign the consent form, and allow the sponsor to use their data for the purposes of this study.

Exclusion criteria

* Refusal or linguistic or mental incapacity to sign the informed consent form; * Person under guardianship (conservatorship, curators, or legal protection) or deprived of liberty; * Person not affiliated with a social security scheme; * Pregnant woman; * Person participating in a drug study; * Women with a medical history (chronic lung disease, heart disease, pharmacologically treated hypertension) or with a known significant chronic inflammatory disease at the time of the enrollment visit; * Person who has already participated in this study in a previous race.

Design outcomes

Primary

MeasureTime frameDescription
Cardiac functionBefore the race, at the 3 refreshment stations, at the arrival of the race, 9 days after the race.Echocardiographic measurements of left ventricular ejection fraction as a percentage
Systemic inflammatory parametersBefore the race, at the 3 refreshment stations, at the arrival of the race, 9 days after the race.Inflammatory profile adjusted for baseline

Secondary

MeasureTime frameDescription
Hormonal parametersBefore the race, at the 3 refreshment stations, at the arrival of the race, 9 days after the race.Hormonal profile adjusted for baseline
Vascular adaptationsBefore the race, at the 3 refreshment stations, at the arrival of the race, 9 days after the race.Carotid artery and femoral artery diameter adjusted for baseline
Defense mechanisms regarding emotional dynamicsBefore the race, at the 3 refreshment stations, at the arrival of the race.Defense Style Questionnaire-26 questionnaire is a standardized questionnaire developed to assess defense mechanisms: adaptive (humor, anticipation, self-assertion, altruism, self-observation) and maladaptive defenses (help rejecting complaining, splitting other, projection, dissociation, intellectualization, devaluation/self, fantasy, devaluation of other). These items are rated on a Likert scale from 1 to 6 points; 1 corresponding to "strongly disagree" and 6 to "strongly agree".

Countries

France

Contacts

CONTACTTessa BERGOT, MSc
tessa.bergot@sfcariod.fr+33144907033
PRINCIPAL_INVESTIGATORRomain JOUFFROY, MD

CHU d'Orléans

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026